DoD to Use CARES Act Funds to Apply AI in COVID-19 Vaccine Testing

DoD to Use CARES Act Funds to Apply AI in COVID-19 Vaccine Testing

The Department of Defense (DoD) plans to use funds allocated under the Coronavirus Aid, Relief and Economic Security (CARES) Act to develop artificial intelligence-based models to accelerate screening and testing of vaccines, antibody-based treatments and other drug candidates for COVID-19, Bloomberg Government reported Monday.

The Pentagon plans to shift $3.8 billion in funds for the Defense Health Program to its research and development accounts to support the AI initiative, according to the department’s spending plan for $10.5 billion in emergency funds under the CARES Act.

The congressional report also outlined how DoD plans to spend $688 million to address the economic impacts of COVID-19 on the defense industrial base, including shipbuilding, aircraft propulsion, microelectronics and space launch.

Check Also

U.S. Air Force

Grand Forks Air Force Base Innovation Council Hosts Virtual Pitch Day

The Grand Forks Air Force Base Innovation Council collaborated with the University of North Dakota and the 319th Contracting Flight to hold a virtual pitch event for startup businesses.